However, patients lacking cutaneous mastocytosis and SM criteria because they meet only 1 or 2 minor criteria according to WHO 2016 criteria (including or not the presence of the KIT 816 mutation) have not previously been well characterized (excluding patients meeting the 3 MCAS criteria so called clonal MCAS). The gene discussed is KIT; the disease is systemic mastocytosis.